Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12190635 | 0.84 | L3MBTL1 (0.48) | KDM4EMAOBAOC3LMNAPKM | |
| SCHEMBL3148903 | 0.84 | KDM4E (0.48) | KDM4EMAOBAOC3LMNAPKM | |
| SCHEMBL817454 | 0.84 | KDM4E (0.48) | KDM4EMAOBAOC3LMNAPKM | |
| SCHEMBL817449 | 0.84 | KDM4E (0.48) | KDM4EMAOBAOC3LMNAPKM | |
| SCHEMBL9988187 | 0.81 | HTR2A (0.57) | KDM4EMAOBAOC3LMNAPKM | |
| SCHEMBL28303221 | 0.79 | L3MBTL1 (0.51) | KDM4EMAOBAOC3LMNAPKM | |
| Hydrochloric Acid SCHEMBL7109951 | 0.78 | L3MBTL1 (0.51) | KDM4EMAOBAOC3LMNAPKM | |
| SCHEMBL4990397 | 0.78 | SCN4A (0.63) | KDM4EMAOBAOC3L3MBTL1 | |
| SCHEMBL14241267 | 0.78 | L3MBTL1 (0.50) | KDM4EMAOBAOC3LMNAPKM | |
| SCHEMBL10578799 | 0.78 | L3MBTL1 (0.50) | KDM4EMAOBAOC3LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2274266-B1 | PROCESS FOR THE PREPARATION OF PROSTAGLANDIN ANALOGUES AND INTERMEDIATES THEREOF | SCINOPHARM TAIWAN LTD (TW) | 2014-10-15 | — | — | EP | disclosed |